The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The histamine H3receptor: an attractive target for the treatment of cognitive disorders
Open accessAbstract
The histamine H 3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous laboratories as it represents an attractive drug target for a number of indications including cognition. The purpose of this review is to acquaint the reader with the current understanding of H 3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H 3 antagonists in various states of preclinical and clinical advancement. Blockade of centrally localized H 3 receptors by selective H 3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes. The cognitive‐enhancing effects of H 3 antagonists across multiple cognitive domains in a wide number of preclinical cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia. However, although a number of clinical studies examining the efficacy of H 3 receptor antagonists for a variety of cognitive disorders are currently underway, no clinical proof of concept for an H 3 receptor antagonist has been reported to date. The discovery of effective H 3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H 3 receptor. British Journal of Pharmacology(2008)154, 1166–1181; doi:10.1038/bjp.2008.147; published online 12 May 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
Arrang, J.-M., Garbarg, M., & Schwartz, J.-C. (1983) · Nature · doi:10.1038/302832a0 · Cited by 1,575
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
MISHKIN, M. (1978) · Nature · doi:10.1038/273297a0 · Cited by 1,196
Cloning and Functional Expression of the Human Histamine H3Receptor
Lovenberg, T. W., Roland, B. L., Wilson, S. J., Jiang, X., Pyati, J., Huvar, A., Jackson, M. R., & Erlander, M. G. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1101 · Cited by 696
The histamine H3 receptor: from gene cloning to H3 receptor drugs
Leurs, R., Bakker, R. A., Timmerman, H., & de Esch, I. J. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1631 · Cited by 485
High constitutive activity of native H3 receptors regulates histamine neurons in brain
Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C. R., & Arrang, J.-M. (2000) · Nature · doi:10.1038/35048583 · Cited by 461
A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain
Pillot, C., Heron, A., Cochois, V, Tardivel-Lacombe, J., Ligneau, X., Schwartz, J.-C., & Arrang, J.-M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00135-5 · Cited by 344
Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors
Schlicker, E., Fink, K., Detzner, M., & G�thert, M. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244933 · Cited by 339
Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex
Schlicker, E., Betz, R., & G�thert, M. (1988) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00182737 · Cited by 311
Medhurst, A. D., Atkins, A. R., Beresford, I. J., Brackenborough, K., Briggs, M. A., Calver, A. R., Cilia, J., Cluderay, J. E., Crook, B., Davis, J. B., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120311 · Cited by 301
Cited by
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Maramai, S., Benchekroun, M., Gabr, M. T., & Yahiaoui, S. (2020) · BioMed Research International · doi:10.1155/2020/5120230 · Cited by 121
The role of histamine receptors in the consolidation of object recognition memory
da Silveira, C. K. B., Furini, C. R. G., Benetti, F., Monteiro, S. D. C., & Izquierdo, I. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.001 · Cited by 53
Barchuk, W. T., Salapatek, A. M., Ge, T., D'Angelo, P., & Liu, X. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.001 · Cited by 31
Metadata
- Authors
- Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D., & Brioni, J. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-07
- Volume
- 154
- Issue
- 6
- Pages
- 1166-1181
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1968695161
- Cited by
- 296
- References
- 83
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The histamine H3receptor: an attractive target for the treatment of cognitive disorders. https://app.cochat.ai/papers/10.1038/bjp.2008.147
- The paper
- Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D., & Brioni, J. D. (2008). The histamine H3receptor: an attractive target for the treatment of cognitive disorders. British Journal of Pharmacology. https://doi.org/10.1038/bjp.2008.147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
